Geneza Pharmaceuticals GP Prima 100 Lab Test Results

Geneza Pharmaceuticals GP Prima 100 is presented in a 10-milliliter multidose vial and reportedly contains 100 milligrams of methenolone enanthate per milliliter according to label and/or packaging. Samples of this product were purchased from a European-based internet source between the dates of August 1, 2016 and September 15, 2016.

The samples were forwarded and received by the analytical laboratory SIMEC AG on September 29, 2016. SIMEC performed HPLC-UV quantitative dosage testing, ‘total aerobial microbiological count’ (TAMC) testing and ‘total yeast and mold count’ (TYMC) testing. The report was completed on November 17, 2016.

The “lot number” listed on the product was GP138CN and the expiration date was March 2018. The ISN number “A4N6814M92DP” was successfully used to verify the authenticity of the product on genezapharmaceuticals.com.

Label claim: Geneza Pharmaceuticals GP Prima 100 has a label claim of 100 mg/ml methenolone enanthate.

Actual content: Geneza Pharmaceuticals GP Prima 100 was determined to have an actual content of 96.4 mg/ml methenolone enanthate.

No microbiological contamination was detected.

Discuss the Geneza Pharmaceuticals GP Prima 100 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Geneza Pharma GP Prima 100 Dosage Quantification Lab Results [PDF]
Does Geneza Pharma GP Prima 100 contain 100 milligrams of methenolone enanthate in each milliliter of solution? HPLC-UV, TAMC, TYMC (November 17, 2016) ...

Size	2.52 MB
Downloaded	433 times
Last Updated	November 21, 2016
Download

---